Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Livia Rojko"'
Autor:
Livia Rojko, Zsolt Megyesfalvi, Eszter Czibula, Lilla Reiniger, Vanda Teglasi, Zsolt Szegedi, Zoltan Szallasi, Balazs Dome, Judit Moldvay
Publikováno v:
Thoracic Cancer, Vol 11, Iss 11, Pp 3193-3204 (2020)
Background Metastatic lung cancer is a debilitating disease, but with the advances in immunotherapy, therapeutic options have vastly increased. Numerous complete blood count parameters (CBC) have been described as easily accessible biomarkers that mi
Externí odkaz:
https://doaj.org/article/8d86fa3320a8435ab281b82d037f5719
Autor:
Anna Kerpel-Fronius, Zsuzsanna Monostori, Gabor Kovacs, Gyula Ostoros, Istvan Horvath, Diana Solymosi, Orsolya Pipek, Ferenc Szatmari, Anita Kovacs, Zsolt Markoczy, Livia Rojko, Ferenc Renyi-Vamos, Konrad Hoetzenecker, Krisztina Bogos, Zsolt Megyesfalvi, Balazs Dome
Publikováno v:
European radiology. 32(7)
Lung cancer (LC) kills more people than any other cancer in Hungary. Hence, there is a clear rationale for considering a national screening program. The HUNCHEST pilot program primarily aimed to investigate the feasibility of a population-based LC sc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3470496b1613c67f26ef4fc7e9529110
https://pubmed.ncbi.nlm.nih.gov/35247089
https://pubmed.ncbi.nlm.nih.gov/35247089
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Gyöngyvér Orsolya Sándor, András Áron Soós, Péter Lörincz, Lívia Rojkó, Tünde Harkó, Levente Bogyó, Tamás Tölgyes, Attila Bursics, Edit I. Buzás, Judit Moldvay, Zoltán Wiener
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 9 (2021)
Extracellular vesicles (EV) are considered as a potential tool for early disease diagnosis; however, factors modifying EV release remain partially unknown. By using patient-derived organoids that capture the cellular heterogeneity of epithelial tissu
Externí odkaz:
https://doaj.org/article/7e5fc987ea8c43a19c6538d3a6032bcb
Autor:
Anita Rózsás, Judit Berta, Lívia Rojkó, László Z Horváth, Magdolna Keszthelyi, István Kenessey, Viktória László, Walter Berger, Michael Grusch, Mir Alireza Hoda, Szilvia Török, Walter Klepetko, Ferenc Rényi-Vámos, Balázs Hegedűs, Balázs Döme, József Tóvári
Publikováno v:
PLoS ONE, Vol 8, Iss 10, p e77459 (2013)
Recombinant human erythropoietins (rHuEPOs) are used to treat cancer-related anemia. Recent preclinical studies and clinical trials, however, have raised concerns about the potential tumor-promoting effects of these drugs. Because the clinical signif
Externí odkaz:
https://doaj.org/article/0d6a47523de2473daec437cfe2abf432